PMA

P150029: IPRO2 CGM SYSTEM WITH ENLITE SENSOR

FDA PMA · Sensor, glucose, invasive · Medtronic Minimed

Key facts

PMA number P150029
Trade name IPRO2 CGM SYSTEM WITH ENLITE SENSOR
Generic name Sensor, glucose, invasive
Applicant Medtronic Minimed
Owner/operator Medtronic
Product code MDS
Approval date Jun 17, 2016
Docket number 16m-1755
Notice date Jun 24, 2016
Establishment registration 2032227
FEI number 3003166194

At a glance

  • 10–99 Supplements
  • Apr 29, 2022 Latest supplement decision
  • No Withdrawn
  • Yes Summary of safety and effectiveness on file
  • 100–999 UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals